What is BIAFW's gross margin?

bioAffinity (BIAFW) has a gross margin of -221% and a net margin of -223%.

What is BIAFW's P/E ratio?

Track bioAffinity (BIAFW) P/E ratio, ROE, and valuation metrics over time.

Where can I see BIAFW's full financials?

See bioAffinity (BIAFW) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

bioAffinity (BIAFW) Financials — Revenue, Earnings, Cash Flow

Also trades as: BIAF (NASDAQ) · $vol 13M

$0.33

+0.01 (+3.28%)

Weekly Expected Move ±72.8%

$-0 $0 $0 $1 $1

NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 62 · $11.8M mcap · 4M float · 0.027% daily turnover · Short 11% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest Supply Chain

📊 Key Metrics

TTM

$6M

Revenue

-23.2% YoY

$-15M

Net Income

-29.9% YoY

$-11M

Free Cash Flow

-48.4% YoY

-220.8%

Gross Margin

-220.8%

Op. Margin

-222.8%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-1860.2%

ROA-245.5%

ROIC-352.6%

Valuation

P/E-0.1

P/B0.6

EV/EBITDA0.1

Leverage

Debt/Equity0.38

Current Ratio1.44

Interest Cov.-337.5x

Quality Scores

Piotroski F4/9

Altman Z-19.47

Beneish M-4.50